advancing innovation to save lives

GHTC director profiled in Impact Magazine

GHTC Director Jamie Bay Nishi was profiled in an article by Impact Magazine, covering challenges facing global health research and development (R&D) and the coalition's efforts to better inform policy makers.

Pipeline of Promise

Learn about the global health R&D process through our interactive Pipeline of Promise infographic.
Learn More

International Vaccine Institute

Established in 2000, the International Vaccine Institute's Vaccinology Course is one of the longest running vaccinology courses in the Asia-Pacific region. It helps fulfill the mission of making vaccines available for global health by building capacity in vaccinology and promoting vaccine sustainability in developing countries. The five-day course is from September 4–8, 2017 in Seoul, South Korea, and will provide a comprehensive overview of vaccinology with a focus on practicality.
Learn More

GHTC works to save and improve lives by encouraging the research and development of essential health technologies. We are a coalition of more than 25 nonprofit organizations advancing policies to accelerate the creation of new drugs, vaccines, diagnostics, and other health tools that bring healthy lives within reach for all people.

Why we're needed

Health technologies have the potential to save millions of lives. New tools are needed to slow the global threat of diseases, including HIV/AIDS, malaria, tuberculosis, and neglected tropical diseases, and tackle many other pressing health needs. For diseases and conditions primarily affecting people in the world’s poorest places, there is little to no commercial market to spur R&D. Strong investment and innovative solutions are needed to catalyze the development of new technologies to bring health and opportunity in reach for all people.

Learn more
PATH/Doune Porter
GHTC calls for US engagement in innovative effort to bring vaccines to children worldwide

GlaxoSmithKline and Pfizer today announced that they have joined the first Advance Market Commitment (AMC), a unique funding effort to bring pneumococcal vaccines to millions of children worldwide. GHTC commends increased involvement in the AMC and calls on the United States to participate in innovative health financing mechanisms, including a future AMC, to maximize the life-saving potential of immunizations worldwide.

Learn More
PATH/Patrick McKern
GHTC applauds CSIS Commission report highlighting need for global health research, innovative financing

The Center for Strategic and International Studies (CSIS) today released the final report of its Commission on Smart Global Health Policy, providing recommendations for US policymakers on creating a long-term and strategic approach to global health. GHTC applauds the Commission’s inclusion of research and innovative financing among its recommendations for strengthening US global health programs, developing new products, and bolstering health systems overseas.

Learn More
View All News & Events

Community Event

CDC Connects/Tara Sealy
Ebola, Zika, and AR: Leveraging Diagnostics to Fight Emerging Infectious Disease Threats
CDC, AdvaMedDx
Learn More

Member Event

PATH/Gabe Bienczycki
Growing the bottom line: How investments in health R&D strengthen economies and innovation capacity
Learn More
View All Events
PATH/Claire Suni
Research Roundup: Venom, technology for smart vector control & animals as a human health threat

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
PATH/Lesley Reed
R&D Roundup: Dengue diagnostics, unlocking protein structures, and an antibiotic found in soil

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog

Our members work to improve health worldwide